These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 16573370)

  • 1. Polypharmacy in a 75-year-old patient with schizoaffective disorder.
    Breden EL; Kirkwood CK
    Consult Pharm; 2006 Mar; 21(3):229-34. PubMed ID: 16573370
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Utility of quetiapine in tardive dyskinesia].
    Navarro Pacheco BV; Montejo González AL; Martín Carrasco M
    Actas Esp Psiquiatr; 2003; 31(6):347-52. PubMed ID: 14639511
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A single-blind, randomized trial comparing quetiapine and haloperidol in the treatment of tardive dyskinesia.
    Emsley R; Turner HJ; Schronen J; Botha K; Smit R; Oosthuizen PP
    J Clin Psychiatry; 2004 May; 65(5):696-701. PubMed ID: 15163258
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Incidence and costs of polypharmacy: data from a randomized, double-blind, placebo-controlled study of risperidone and quetiapine in patients with schizophrenia or schizoaffective disorder.
    Rupnow MF; Greenspan A; Gharabawi GM; Kosik-Gonzalez C; Zhu Y; Stahl SM
    Curr Med Res Opin; 2007 Nov; 23(11):2815-22. PubMed ID: 17910802
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Tardive dyskinesia rates with atypical antipsychotics in older adults.
    Jeste DV
    J Clin Psychiatry; 2004; 65 Suppl 9():21-4. PubMed ID: 15189108
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Quetiapine alone and added to a mood stabilizer for serious mood disorders.
    Sajatovic M; Brescan DW; Perez DE; DiGiovanni SK; Hattab H; Ray JB; Bingham CR
    J Clin Psychiatry; 2001 Sep; 62(9):728-32. PubMed ID: 11681770
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Paradoxical severe agitation induced by add-on high-doses quetiapine in schizo-affective disorder.
    Fond G; MacGregor A; Ducasse D; Brittner M
    Psychiatry Res; 2014 May; 216(2):286-7. PubMed ID: 24582773
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Adjunctive quetiapine decreases symptoms of tardive dyskinesia in a patient taking risperidone.
    Nelson MW; Reynolds RR; Kelly DL; Conley RR
    Clin Neuropharmacol; 2003; 26(6):297-8. PubMed ID: 14646608
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Quetiapine in the successful combination treatment of an assaultive patient with treatment-resistant schizoaffective disorder.
    Post DE
    Behav Med; 2007; 33(1):11-4. PubMed ID: 17517541
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Tardive dyskinesia with quetiapine.
    Ghelber D; Belmaker RH
    Am J Psychiatry; 1999 May; 156(5):796-7. PubMed ID: 10327920
    [No Abstract]   [Full Text] [Related]  

  • 11. Open-label study of the effect of combination quetiapine/lithium therapy on lithium pharmacokinetics and tolerability.
    Potkin SG; Thyrum PT; Bera R; Carreon D; Alva G; Kalali AH; Yeh C
    Clin Ther; 2002 Nov; 24(11):1809-23. PubMed ID: 12501876
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Schizoaffective disorder: clinical symptoms and present-day approach to treatment].
    Danileviciūte V
    Medicina (Kaunas); 2002; 38(11):1057-65. PubMed ID: 12532717
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Efficacy of quetiapine and risperidone against depressive symptoms in outpatients with psychosis.
    Sajatovic M; Mullen JA; Sweitzer DE
    J Clin Psychiatry; 2002 Dec; 63(12):1156-63. PubMed ID: 12523876
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Possible intranasal quetiapine misuse.
    Morin AK
    Am J Health Syst Pharm; 2007 Apr; 64(7):723-5. PubMed ID: 17384357
    [TBL] [Abstract][Full Text] [Related]  

  • 15. No recurrence of a neuroleptic malignant syndrome under quetiapine.
    Brieger P; Reinelt Y
    Aust N Z J Psychiatry; 2003 Oct; 37(5):627. PubMed ID: 14511095
    [No Abstract]   [Full Text] [Related]  

  • 16. Quetiapine-related tardive dyskinesia.
    Ghaemi SN; Ko JY
    Am J Psychiatry; 2001 Oct; 158(10):1737. PubMed ID: 11579018
    [No Abstract]   [Full Text] [Related]  

  • 17. Long-term safety, tolerability, and clinical efficacy of quetiapine in adolescents: an open-label extension trial.
    McConville B; Carrero L; Sweitzer D; Potter L; Chaney R; Foster K; Sorter M; Friedman L; Browne K
    J Child Adolesc Psychopharmacol; 2003; 13(1):75-82. PubMed ID: 12804128
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Antiaggressive effect of quetiapine in a patient with schizoaffective disorder.
    Citrome L; Krakowski M; Greenberg WM; Andrade E; Volavka J
    J Clin Psychiatry; 2001 Nov; 62(11):901. PubMed ID: 11775051
    [No Abstract]   [Full Text] [Related]  

  • 19. Quetiapine in the treatment of focal tardive dystonia induced by other atypical antipsychotics: a report of 2 cases.
    Gourzis P; Polychronopoulos P; Papapetropoulos S; Assimakopoulos K; Argyriou AA; Beratis S
    Clin Neuropharmacol; 2005; 28(4):195-6. PubMed ID: 16062102
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Reducing Anticholinergic Medication Burden in Patients With Psychotic or Bipolar Disorders.
    Lupu AM; Clinebell K; Gannon JM; Ellison JC; Chengappa KNR
    J Clin Psychiatry; 2017; 78(9):e1270-e1275. PubMed ID: 29178683
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.